Case Study

Metabolomics Reveals Oxidative Stress Metabolites Involved in Long-term Weight Gain

Metabolomic profiling in a large cohort provides deeper insights into metabolic health by revealing a link between oxidative stress metabolites and increased long-term weight gain.

In this study, researchers sought to understand the relationship between metabolites and changes in weight over time. Leveraging data from TwinsUK, a large cohort study, with untargeted metabolomic profiling using the Metabolon Global Discovery Panel, their findings identified four metabolites that were significantly associated with long-term weight gain. Notably, these metabolites have been previously linked to increased oxidative stress, suggesting that long-term body weight increase is partly driven by metabolites that modulate reactive oxygen species (ROS).

In this study, researchers sought to understand the relationship between metabolites and changes in weight over time. Leveraging data from TwinsUK, a large cohort study, with untargeted metabolomic profiling using the Metabolon Global Discovery Panel, their findings identified four metabolites that were significantly associated with long-term weight gain. Notably, these metabolites have been previously linked to increased oxidative stress, suggesting that long-term body weight increase is partly driven by metabolites that modulate reactive oxygen species (ROS).

Metabolomics Reveals Oxidative Stress Metabolites Involved in Long-term Weight Gain

The Challenge: Understanding the Molecular Pathways Associated with Long-term Weight Gain

Untargeted metabolomic profiling has provided considerable insight into the mechanisms and processes that drive excess weight gain in obese individuals. However, previous metabolomics research has leveraged mainly cross-sectional study designs, leaving an important gap in our understanding of alterations in obesity-related metabolites over time and how these metabolite changes impact long-term weight gain. To address this knowledge gap, researchers obtained longitudinal BMI data and performed untargeted metabolomic profiling on fasting blood samples from 3,176 females from the TwinUK study.

The Metabolon Insight: Linking Metabolites with Long-term Changes in Weight

To link metabolites with long-term weight changes, the researchers leveraged the Global Discovery Panel, which provides an unbiased view of all of the metabolites present in a sample, including amino acids, acylcarnitines, sphingomyelins, glycerophospholipids, carbohydrates, vitamins, lipids, nucleotides, peptides, xenobiotics, and steroids. The researchers applied linear regression analysis to link these metabolites with weight gain over ~9 years.

The Solution: A Role for Oxidative Stress Metabolites and Increased Weight Over Time

After adjusting for age, BMI at baseline, smoking, metabolite batch, and family relatedness, linear regression analyses revealed four metabolites independently associated with long-term weight change. Specifically, urate, gamma-glutamyl valine, and butyrylcarnitine exhibited positive associations with weight gain, while 3-phenylpropionate was negatively associated with weight gain.

These metabolites are not only altered in obesity and type-2 diabetes, but also play important roles in mediating oxidative stress. Notably, urate has been closely linked with increased risk of metabolic syndrome and is a marker for intracellular prooxidant and inflammatory status. Gamma-glutamyl valine is a widely used marker for elevated oxidative stress and also reflects glutathione turnover, a protective process against oxidative damage. Butyrylcarnitine is closely associated with insulin resistance, and high levels of butyrylcarnitine indicate incomplete beta-oxidation and a driver for increased reactive oxygen species (ROS). Finally, 3-phenylpropionate provides antioxidant effects, and decreased 3-phenylpropionate has been previously linked with weight gain.

To understand whether these metabolites might be predictive of future weight gain, the current report further investigated the interaction between baseline urate and changes in fatty acids within individuals who gained or lost weight, observing a positive association between urate, total fatty acids, and saturated fatty acids in individuals who gained weight. Conversely, lower polyunsaturated fatty acids were associated with elevated circulating urate in individuals who lost weight.

The Outcome: Insights into Metabolites Obesity Risk Indicators

These data provide important insights into the relationship between metabolite alterations and longitudinal body weight changes. Leveraging a large cohort study with untargeted metabolomics profiling revealed oxidative stress metabolites as novel indicators of long-term body weight changes, highlighting these metabolites as potentially robust biomarkers for identifying obesity risk, monitoring metabolic syndrome, and identifying novel therapeutic targets.

References

1. Menni C, Migaud M, Kastenmüller, et al. Metabolomic Profiling of Long-Term Weight Change: Role of Oxidative Stress and Urate Levels in Weight Gain. Obesity 2017;(25):1618-1624.

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.